Kim et al. reported PIK3CA amplification in 10.5% of ESCC patients undergoing curative esophageal resection; patients with PIK3CA amplification displayed a significantly shorter disease-free survival rate compared with those without this amplification [78]. The gene discussed is PIK3CA; the disease is esophageal squamous cell carcinoma.